InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Karabelas Argeris N. Officer active across 2 companies, notably Bausch Health Companies Inc.. Cumulatively, 11 filings have been logged. Activity tracked since 30 April 2021. The latest transaction was filed on 30 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Karabelas Argeris N
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
7,768 shares0Common StockSEC:0001562180-25-004348:0
10,000 shares@ US$3.7612.7% of flowCommon StockSEC:0001562180-24-007144:0
10,000 shares@ US$3.7612.7% of flowCommon StockSEC:0001562180-24-006657:0
10,000 shares@ US$3.7613.0% of flowCommon StockSEC:0001562180-24-006015:0
11,000 shares@ US$12.7448.4% of flowCommon StockSEC:0001562180-24-005875:0
10,000 shares@ US$3.7613.1% of flowCommon StockSEC:0001562180-24-005566:0
4,790 shares0Common StockSEC:0001562180-24-004654:0
3,486 shares0Common StockSEC:0001562180-23-004890:0
34,387 shares0Common Shares, No Par ValueSEC:0001127602-22-018201:0
3,010 shares0Common StockSEC:0001562180-22-004878:0
7,645 shares0Common Shares, No Par ValueSEC:0001127602-21-014909:0
11 of 11 declarations
About Karabelas Argeris N
KARABELAS ARGERIS N is a declarant and a director of REGENXBIO Inc. and Bausch Health Companies Inc. The declarant has 11 filings in total, and the 11 sampled filings run from 2021-05-03 to 2024-10-02, with transaction nature shown as Attribution and buy and sell amounts of 0 in this recent sample.
